Arkolith/Insider Trading/SONN/Form 4

Kenney Richard T

Chief Medical OfficerSonnet BioTherapeutics Holdings, Inc. (SONN) · full profile →Form 4 · filed Aug 21, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
0 non-derivative · 3 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 14, 2025Grant(A)320K——320K
Jul 14, 2025Grant(A)200——200
Jun 30, 2025Grant(A)87K——87K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001641172-25-025100) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML